Video Registration Login


Acceleration programs with Big Pharma: experience in supporting new developments

SKOLKOVO HALL, October, 16, 11:30 — 12:30

In recent years, large pharmaceutical companies have increasingly become partners or organizers of innovative project competitions and acceleration programs for start-ups in Russia.

  • What are the goals and objectives set by large companies when working with accelerators?
  • How to build effective and long-term cooperation with partners and program participants?

Leaders of the pharmaceutical industry and start-ups that have gone through corporate acceleration programs will share their experience in Russia and abroad.

Ruslan Altaev, Skolkovo Foundation, Development and Key Partners Director, Biomedical Technologies Cluster


  • Igor Orshanskiy, Bayer, External Innovation and Alliances Manager
  • Anna Ulianova, Bayer, Senior Public and Government Affairs Advisor Pharma
  • Kira Blong, AstraZeneca, Medical director, Russia&Eurasia
  • Alexei Kliuchenovich, Target Medicals, CEO
  • Dmitrii Pakhomov, Janssen, New Business Development Director, Russia & CIS
  • Kamila Zarubina, Skolkovo Foundation, Accelerataion director
  • Nikolai Kovtunenko, Gero, CEO